| Title： | Expert consensus on prevention and treatment of LongMengShaHou (rheumatoid arthritis) by Dai medicine |
| Edition： | Original |
| Classification： | Experts consensus |
| Field： | Comprehensive guideline |
| Countries and regions： | China |
| Guidelines users： | This specification is applicable to guide the medical personnel of Dai medicine, traditional Chinese medicine, traditional Chinese medicine and integrated Chinese and Western medicine in ethnic medicine hospitals, Chinese medicine hospitals, integrated Chinese and Western medicine hospitals, general hospitals and primary hospitals, etc., to refer to this Consensus in their clinical practice and to provide patients with rheumatoid arthritis with a more comprehensive and individualized treatment plan. |
| Evidence classification method： | Evidence search combined with expert consensus |
| Development unit： | Yunnan Traditional Chinese Medicine Hospital (the First Affiliated Hospital of Yunnan University of Traditional Chinese Medicine) and Xishuangbanna Dai Medicine Hospital |
| Registration time: | 2024-10-07 |
| Registration number： | PREPARE-2024CN755 |
| Purpose of the guideline: | Dai medicine has unique advantages and clinical efficacy in the prevention and treatment of rheumatoid arthritis, but a standardized expert consensus on the prevention and treatment of rheumatoid arthritis by Dai medicine has not yet been established. This expert consensus aims to give full play to the characteristic advantages of Dai medicine, standardize the clinical practice of Dai medicine in the prevention and treatment of rheumatoid arthritis, guide physicians in clinical decision-making, and enhance the influence and recognition of Dai medicine. |
Latest registration
